Medical Technology Acceleration Service Limited (‘MTAS”), an Australian based, medical technology fund.
- A funding and advisory platform for early-stage Med-Tech assets with high growth potential.
- Founders have decades of high returns in both the private and public markets
- Investments in high potential med tech companies in Australia, New Zealand and the USA.
- Pre-IPO offering and will be publicly listed in 2023; anticipated to list at a multiple of the current entry price subject to market conditions.
- Opum Technologies - Wearable technologies for musculoskeletal treatment and proprietary health data. USD 2 billion in knee brace sales alone. Supported by the University of Auckland (NZ).
- Clinx – Day treatment facilities servicing rapidly growing outpatient / elective surgery space.
- Mirus - Industry leading aged care advisory and workforce optimisation SaaS with 12-year history and scaling growth. Most trusted brand in the sector and deep longstanding public & private system integrations via superior tech
- Prostacare - Break-through treatment for benign prostate growth addressing a very large and well understood unmet need. Pre-commercialisation supported by clinically validated efficacy and robust FDA & TGA pathways
- ‘Med-Tech Acceleration Services’ is based in Sydney
- MTAS finances high growth emerging health sector assets
- ROI target of 3-5 times within 24 months of taking a position
- Unique domain expertise, a proven model & strong track record
- De-risked assets in co-investment portfolio
- Break-through & patented BPH treatment
- Fills huge unmet market need between medications & much more invasive procedures
- Proven efficacy with low pain & low cost
- Endorsed by world-leading urologists
- Australia’s leading aged care advisor
- Most trusted brand in aged care
- Strong revenues, margin & growth profile
- Market dominant with many natural acquirers
- Recognised as world’s leading knee sensor
- Going-to-market with leading knee brace makers
- Clinically proven for osteoarthritis care
- Setting the standard for the massive growth sector of Remote Patient Monitoring
